Moreover, SGRMs promote GR transrepression, which directs the anti-inflammatory effects of GCs, thereby reducing those adverse effects associated with GR transactivation, such as osteoporosis, hyperglycemia, and myopathies [95]. This evidence concerns the gene NR3C1 and Hyperglycemia.